Background2D angiographic parametric imaging (API) quantitatively extracts imaging biomarkers related to contrast flow and is conventionally applied to 2D digitally subtracted angiograms (DSA's). In the interventional suite, API is typically performed using 1–2 projection views and is limited by vessel overlap, foreshortening, and depth‐integration of contrast motion.PurposeThis work explores the use of a pathlength‐correction metric to overcome the limitations of 2D‐API: the primary objective was to study the effect of converting 3D contrast flow to projected contrast flow using a simulated angiographic framework created with computational fluid dynamics (CFD) simulations, thereby removing acquisition variability.MethodsThe pathlength‐correction framework was applied to in‐silico angiograms, generating a reference (i.e., ground‐truth) volumetric contrast distribution in four patient‐specific intracranial aneurysm geometries. Biplane projections of contrast flow were created from the reference volumetric contrast distributions, assuming a cone‐beam geometry. A Parker‐weighted reconstruction was performed to obtain a binary representation of the vessel structure in 3D. Standard ray tracing techniques were then used to track the intersection of a ray from the focal spot with each voxel of the reconstructed vessel wall to a pixel in the detector plane. The lengths of each ray through the 3D vessel lumen were then projected along each ray‐path to create a pathlength‐correction map, where the pixel intensity in the detector plane corresponds to the vessel width along each source‐detector ray. By dividing the projection sequences with this correction map, 2D pathlength‐corrected in‐silico angiograms were obtained. We then performed voxel‐wise (3D) API on the ground‐truth contrast distribution and compared it to pixel‐wise (2D) API, both with and without pathlength correction for each biplane view. The percentage difference (PD) between the resultant API biomarkers in each dataset were calculated within the aneurysm region of interest (ROI).ResultsIntensity‐based API parameters, such as the area under the curve (AUC) and peak height (PH), exhibited notable changes in magnitude and spatial distribution following pathlength correction: these now accurately represent conservation of mass of injected contrast media within each arterial geometry and accurately reflect regions of stagnation and recirculation in each aneurysm ROI. Improved agreement was observed between these biomarkers in the pathlength‐corrected biplane maps: the maximum PD within the aneurysm ROI is 3.3% with pathlength correction and 47.7% without pathlength correction. As expected, improved agreement with ROI‐averaged ground‐truth 3D counterparts was observed for all aneurysm geometries, particularly large aneurysms: the maximum PD for both AUC and PH was 5.8%. Temporal parameters (mean transit time, MTT, time‐to‐peak, TTP, time‐to‐arrival, TTA) remained unaffected after pathlength correction.ConclusionsThis study indicates that the values of intensity‐based API parameters obtained with conventional 2D‐API, without pathlength correction, are highly dependent on the projection orientation, and uncorrected API should be avoided for hemodynamic analysis. The proposed metric can standardize 2D API‐derived biomarkers independent of projection orientation, potentially improving the diagnostic value of all acquired 2D‐DSA's. Integration of a pathlength correction map into the imaging process can allow for improved interpretation of biomarkers in 2D space, which may lead to improved diagnostic accuracy during procedures involving the cerebral vasculature.
